Story perspectives

Insilico Partners with UAE Amid Rising Regional Tensions

3/6/2026

Summary

Story summary

Insilico Medicine, a Hong Kong-listed company, partnered with the Emirates Drug Establishment, UAE's regulator, to advance AI-enabled drug discovery at the World Health Expo in Dubai.
The agreement coincides with US and Israeli strikes on Iran that escalated regional tensions.
Insilico's shares rose 8.6% on Thursday, outpacing the Hang Seng's 5% drop since the conflict began.
Shaikha Al Mazrouei of the Emirates Drug Establishment said the collaboration uses AI.

1 of 1

Story summary

Insilico Medicine, a Hong Kong-listed company, partnered with the Emirates Drug Establishment, UAE's regulator, to advance AI-enabled drug discovery at the World Health Expo in Dubai.
The agreement coincides with US and Israeli strikes on Iran that escalated regional tensions.
Insilico's shares rose 8.6% on Thursday, outpacing the Hang Seng's 5% drop since the conflict began.
Shaikha Al Mazrouei of the Emirates Drug Establishment said the collaboration uses AI.